Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
‘Met een digitaal overzicht van stroke-bedden is veel te winnen’
aug 2023 | Neuro-vasculair